Independent news and intelligence for the evolving peptide industry.

PepNews tracks the developments shaping peptide research, regulation, compounding, telehealth, and the businesses building around them.

Trending now

FDA Advisory Panel Narrowly Backs Easier Compounding Access for Several Peptides